Eupraxia Pharmaceuticals (TSE:EPRX) has released an update.
Eupraxia Pharmaceuticals Inc. has released its consolidated financial statements for the first half of 2024, revealing an increase in total assets to $24.9 million from $20.2 million at the end of the previous year. The company’s liabilities have also decreased to $11.6 million from $19.3 million, with the shareholders’ equity showing a significant uptick from $892,326 to $13.3 million over the same period.
For further insights into TSE:EPRX stock, check out TipRanks’ Stock Analysis page.
